Rape Trial

Business

Korro Bio Unveils RNA-Editing Therapy KRRO-121, Aiming to Redefine Ammonia Control for Rare Metabolic and Liver Disorders

At its Analyst Day, Korro Bio detailed its lead candidate KRRO-121, an RNA-editing therapeutic designed to tackle hyperammonemia in urea cycle disorders and hepatic encephalopathy by stabilizing a key liver enzyme, positioning it as a potential paradigm shift from current burdensome treatments.

Jan 30, 2026

Business

Donaldson Company's Valuation Under Scrutiny Following Stellar 47% Annual Return

After delivering a 47.6% total shareholder return over the past year, industrial filtration leader Donaldson Company (NYSE: DCI) is facing renewed investor debate. With shares now trading near $101, analysts question whether its premium valuation fully reflects future growth prospects amid shifting industrial demand cycles.

Feb 3, 2026

Business

EnerSys Poised for Q4 Earnings Release: Key Metrics and Market Sentiment in Focus

Industrial battery giant EnerSys (ENS) is set to report its fiscal fourth-quarter results after Wednesday's market close. Investors are weighing strong recent performance against a history of revenue misses and a tempered growth outlook.

Feb 3, 2026

Business

Silgan Holdings Q4 Earnings Preview: Can Packaging Giant Sustain Momentum Amid Slowing Growth?

Silgan Holdings is set to report fourth-quarter earnings Wednesday morning, with Wall Street eyeing slowing revenue growth and the company's ability to outperform in a mixed industrial packaging landscape.

Feb 3, 2026

Business

Stanley Black & Decker Earnings Preview: Can the Toolmaker Regain Its Edge?

All eyes are on Stanley Black & Decker (SWK) as it prepares to release its quarterly earnings. Investors are looking for signs of a sustained turnaround amid a mixed industrial machinery landscape.

Feb 3, 2026

Business

IDEX Earnings on Deck: Analysts Eye Modest Growth Amid Sector Momentum

Industrial manufacturer IDEX (IEX) is set to release its quarterly results Wednesday morning, with Wall Street anticipating a slight revenue increase. The report comes amid a broader rally in fluid and gas handling stocks.

Feb 3, 2026

Business

Musk Merges xAI with SpaceX, Pivots AI Ambitions to Orbit Amid Earth's Infrastructure Limits

Elon Musk announces the integration of his AI startup xAI into SpaceX, citing terrestrial power and cooling constraints as a catalyst for moving advanced computing into space, with the Starship program central to the ambitious orbital data center vision.

Feb 3, 2026

Business

From Bitcoin Miner to AI Powerhouse: How Cipher Mining Is Fueling the Data Center Boom

Cipher Mining Inc. (CIFR), once a traditional cryptocurrency miner, has rapidly transformed into a key developer of industrial-scale data centers, capitalizing on the insatiable power demands of artificial intelligence. With a portfolio exceeding 3 gigawatts, primarily in power-rich West Texas, the company is now building the physical backbone for tech giants. This strategic pivot, however, raises critical questions about capital allocation and the sustainability of the AI infrastructure rush.

Feb 3, 2026

Business

REV Group Merges Into Terex, Shifting Investor Landscape and Strategic Focus

The completion of REV Group's merger with Terex Corporation marks a significant corporate realignment, moving the specialty vehicle manufacturer from a standalone NYSE listing to a subsidiary within a larger industrial equipment platform. This restructuring alters how investors track performance and assess exposure to key markets like emergency services and recreational vehicles.

Feb 3, 2026

Business

Woodward's Dividend Boost and Strong Earnings Fuel Investor Debate on Valuation

Aerospace and industrial systems supplier Woodward (WWD) has raised its dividend by 14% on the back of robust first-quarter sales and profit growth. The move signals management's confidence but also prompts fresh scrutiny over whether the stock's current price fully reflects its cyclical positioning and future prospects.

Feb 3, 2026

Business

Bristol-Myers Squibb Bets $1.5 Billion on RNA Future to Counter Patent Cliff

Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.

Feb 3, 2026

Business

Woodward Soars on Strong Aerospace Demand, Announces China On-Highway Exit

Woodward (WWD) kicked off fiscal 2026 with robust earnings, driven by a surge in aerospace services and industrial sales. The company raised its full-year outlook but cautioned on supply chain pressures and announced a strategic wind-down of its volatile China On-Highway business.

Feb 2, 2026

Business

Caterpillar Powers Up: Inks Major Deal to Fuel AI Data Center Boom with Monarch Campus

Industrial giant Caterpillar secures a landmark agreement to supply 2 gigawatts of power generation and storage to the Monarch Compute Campus, positioning itself at the forefront of meeting the surging energy demands of artificial intelligence infrastructure.

Feb 2, 2026

Business

GM's Barra Joins Trump for Critical Minerals Reserve Announcement, Stressing Supply Chain Resilience

General Motors CEO Mary Barra attended a White House event where President Trump unveiled 'Project Vault,' a $12 billion initiative to create a strategic reserve of critical minerals aimed at securing U.S. industrial supply chains.

Feb 2, 2026

Business

Beyond the Chatbot: Veteran Analyst Pivots AI Investment Thesis to Physical World, Backs Tesla and Nvidia

As Wall Street remains fixated on software-based AI, a leading tech analyst argues the next trillion-dollar opportunity lies in 'physical AI'—machines that see, move, and act. Dan Ives of Wedbush singles out Tesla and Nvidia as the indispensable architects of this new industrial revolution.

Feb 2, 2026

Business

Caterpillar's AI-Powered Surge: Can the Dow's 2025 Champion Keep Climbing in 2026?

Caterpillar, the industrial titan, rode the AI infrastructure wave to become the top-performing Dow stock in 2025. With record earnings on the horizon, investors are asking if its momentum can defy high valuations and continue into the new year.

Feb 2, 2026

Business

Silver's Meteoric Rise: Analysts See Path to $150 as New Era Dawns

Silver's explosive surge past $100 has reshaped the commodity landscape. With Citi and prominent strategists forecasting a run toward $150, the metal is now seen as a volatile barometer of macro fears, structural deficits, and relentless industrial demand, establishing a potential new floor above $65.

Feb 2, 2026

Business

Manufacturing Rebound Fuels Wall Street Gains, Offsetting China Concerns and Shutdown Jitters

U.S. stocks advanced Monday, buoyed by a surprisingly strong manufacturing report that overshadowed lingering concerns over a partial government shutdown and weak economic data from China. The S&P 500 and Dow Jones Industrial Average both closed higher, led by a rebound in semiconductor and AI-related shares.

Feb 2, 2026

Business

3M's Rocky Road: Analysts Hold Steady Despite Stock Lagging Behind Market Rally

While 3M shares have significantly underperformed the broader market and its industrial peers over the past year, Wall Street maintains a cautiously optimistic stance, betting on the diversified giant's long-term recovery and earnings resilience.

Feb 2, 2026

Business

FDA Delays Aquestive's Anaphylm Epinephrine Film, Demands Human Factors Revisions

The FDA has issued a complete response letter for Aquestive Therapeutics' sublingual epinephrine film Anaphylm, citing concerns over packaging and user instructions. The company aims to address the issues and resubmit its application by the third quarter of this year.

Feb 2, 2026